Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Hormonally Balanced vs Lean Rx

Hormonally Balanced
Graded #413

Lower grade

vs+4.200000000000003
Lean Rx
Graded #319

Higher grade

The verdict

Lean Rx takes it — 60.6/100 to 56.4/100.

Lean Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Lean Rx is a Sacramento-based telehealth technology platform offering compounded GLP-1 weight loss medications.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHormonally Balanced +5
45
40
Dose & formulationLean Rx +35
40
75
Clinical oversightLean Rx +1
80
81
Labs & monitoringHormonally Balanced +1
53
52
FulfillmentHormonally Balanced +13
73
60
Contract termsEven
55
55
Hormonally Balanced · left barLean Rx · right bar

The numbers

MetricHormonally BalancedLean Rx
WeighScore56.4/10060.6/100
GradeCC
Scorecard rank#413#319
SemaglutideNot disclosed$266/mo (starting dose, compounded)
TirzepatideNot disclosed$399/mo (starting dose, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Hormonally Balanced

Graded #413 · C

Strengths

  • Physician-led women's hormone clinic with concierge model
  • Nationwide telehealth availability
  • Semaglutide integrated with hormone care for women
  • Named physician (Dr. Zachareas) oversees prescriptions

Where it loses points

  • No pricing published online; must call or submit a form
  • Weight loss is secondary to menopause/hormone focus
  • Semaglutide only; no tirzepatide listed
  • Compounded vs brand formulation not disclosed
Lean Rx

Graded #319 · C

Strengths

  • Both semaglutide and tirzepatide offered
  • Three formulations: injectable, sublingual, and tablet
  • Upfront pricing with no hidden fees advertised
  • Semaglutide starts at a low $266/month
  • Telehealth call with a licensed provider before prescribing

Where it loses points

  • Compounded-only; no FDA-approved branded options
  • No published state availability list
  • Platform is technology only, not a healthcare provider itself
  • Provider credentials not detailed on site

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard